Centre Hospitalier Universitaire de Clermont Ferrand, Hôpital Estaing

Clermont-Ferrand 63003

0 studies enrolling now · 1 studies all time

What they study most

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma

Studies at this site

• Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression — Completed